Effects of estradiol on biological age measured using the glycan age index.
aging biomarkers
biological age
estrogen
glycan age
glycosylation
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
13 Oct 2020
13 Oct 2020
Historique:
received:
26
06
2020
accepted:
25
08
2020
pubmed:
14
10
2020
medline:
14
10
2020
entrez:
13
10
2020
Statut:
ppublish
Résumé
Glycan age is a recently developed biomarker based on glycans attached to immunoglobulin G (IgG). In large population cohorts, glycan age associates well with lifestyle and disease-risk biomarkers, while some studies suggested that glycan changes precede development of several age-associated diseases. In this study we evaluated effects of estrogen on the glycan age. Gonadal hormones were suppressed in 36 healthy young women by gonadotropin releasing hormone agonist therapy for 6 months. In 15 of them estradiol was supplemented, while 21 received placebo resulting in very low estrogen levels during intervention. IgG was isolated from plasma samples before intervention, after 6 months of intervention and after subsequent 4-month recovery. Deprivation of gonadal hormones resulted in median increase of glycan age for 9.1 years (IQR 6.8 - 11.5 years, p = 3.73×10
Identifiants
pubmed: 33049709
pii: 104060
doi: 10.18632/aging.104060
pmc: PMC7732334
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19756-19765Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK048520
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD073063
Pays : United States
Organisme : NIA NIH HHS
ID : U54 AG062319
Pays : United States